Becker’s Hospital Review has named Anka to its 2026 list of “Revenue Cycle Management Companies to Know.” The recognition comes at a time when US healthcare leaders are moving away from traditional analytics dashboards in favor of direct, autonomous claim resolution.
For mid-market and rural hospitals, the revenue cycle has reached a tipping point. Operational costs are climbing while reimbursement complexities intensify. Simply seeing the data is no longer enough; hospitals need the ability to act on it without increasing headcount. Becker’s inclusion of Anka highlights a broader industry shift toward tools that provide tangible control over accounts receivable (AR).
Anka’s approach centers on what we call “Execution AI.” Unlike legacy systems that flag problems for manual review, Anka’s technology focuses on the autonomous recovery of denied claims and the systematic clearing of aged AR. By automating the appeal process rather than just notifying teams of denials, hospital leaders can secure cash flow without adding administrative burden.
Being named by Becker’s is a reflection of the market’s demand for results over rhetoric. CFOs and Rev Cycle leaders are tired of “insights” that sit in a queue. They need the claim resolved, the appeal sent, and the cash collected. We provide the mechanism to do that.
Madhav Garg, CEO of Anka
As hospitals finalize their 2026 financial strategies, the focus remains clear: stabilizing the bottom line through reliable, autonomous execution. For Anka, this recognition validates a commitment to providing grounded, operator-focused technology that returns control to the hospital C-suite.
About Anka
Anka (formerly Jindal Healthcare) provides Execution AI for the US healthcare market, specializing in autonomous denial appeals and accounts receivable recovery for mid-market and rural hospitals.
Visit ankahealth.ai →